 Syndecan-1
"Syndecan-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A syndecan that interacts with EXTRACELLULAR MATRIX PROTEINS and plays a role CELL PROLIFERATION and CELL MIGRATION.
| Descriptor ID |
D053668
|
| MeSH Number(s) |
D12.776.395.550.847.100 D12.776.395.650.350.500.100 D12.776.543.550.847.100 D23.050.301.264.035.916 D23.101.100.110.940
|
| Concept/Terms |
Syndecan-1- Syndecan-1
- Syndecan 1
- CD138 Antigens
- Antigens, CD138
- CD138 Antigen
- Antigen, CD138
|
Below are MeSH descriptors whose meaning is more general than "Syndecan-1".
Below are MeSH descriptors whose meaning is more specific than "Syndecan-1".
This graph shows the total number of publications written about "Syndecan-1" by people in this website by year, and whether "Syndecan-1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 1 | 1 | 2 | | 2012 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Syndecan-1" by people in Profiles.
-
Anderson TN, Hinson HE, Dewey EN, Rick EA, Schreiber MA, Rowell SE. Early Tranexamic Acid Administration After Traumatic Brain Injury Is Associated With Reduced Syndecan-1 and Angiopoietin-2 in Patients With Traumatic Intracranial Hemorrhage. J Head Trauma Rehabil. 2020 Sep/Oct; 35(5):317-323.
-
Zhou Y, Unno K, Hyjek E, Liu H, Zimmerman T, Karmakar S, Putt KS, Shen J, Low PS, Wickrema A. Expression of functional folate receptors in multiple myeloma. Leuk Lymphoma. 2018 12; 59(12):2982-2989.
-
Gandley RE, Althouse A, Jeyabalan A, Bregand-White JM, McGonigal S, Myerski AC, Gallaher M, Powers RW, Hubel CA. Low Soluble Syndecan-1 Precedes Preeclampsia. PLoS One. 2016; 11(6):e0157608.
-
Roberts MJ, Chadburn A, Ma S, Hyjek E, Peterson LC. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. Am J Clin Pathol. 2013 Feb; 139(2):210-9.
-
Chang A, Moore JM, Cowan ML, Josephson MA, Chon WJ, Sciammas R, Du Z, Marino SR, Meehan SM, Millis M, David MZ, Williams JW, Chong AS. Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection. Transpl Int. 2012 Oct; 25(10):1050-8.
-
Kaplan B, Jie T, Diana R, Renz J, Whinery A, Stubbs N, Bracamonte E, Spier C, Schubart P, Rilo H, Gruessner R. Histopathology and immunophenotype of the spleen during acute antibody-mediated rejection. Am J Transplant. 2010 May; 10(5):1316-20.
-
Unno K, Zhou Y, Zimmerman T, Platanias LC, Wickrema A. Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma. Leuk Lymphoma. 2009 Nov; 50(11):1865-71.
-
Hayashida A, Bartlett AH, Foster TJ, Park PW. Staphylococcus aureus beta-toxin induces lung injury through syndecan-1. Am J Pathol. 2009 Feb; 174(2):509-18.
-
Hayashida K, Chen Y, Bartlett AH, Park PW. Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock. J Biol Chem. 2008 Jul 18; 283(29):19895-903.
-
Paessler M, Kossev P, Tsai D, Raghunath P, Majewski M, Zhang Q, Ramalingam P, Schuster S, Tomaszewski J, Arber DA, Hsi E, Wasik MA. Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders. Lab Invest. 2002 Nov; 82(11):1599-606.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|